AI
Wednesday, April 15, 2015 1:05:46 PM
ALNY nearing all time highs while over bought in all time frames. Can this thing really breakout after the huge effort to get this back all time highs?
http://finance.yahoo.com/news/alnylam-reports-publication-data-hemophilia-204508874.html
"Alnylam currently has no approved product in its portfolio. Although the company has a number of pipeline candidates, most of the candidates are in early or mid stages of development. The company has only a couple of late-stage candidates in its pipeline – patisiran (TTR-mediated amyloidosis in familial amyloidotic polyneuropathy patients – phase III) and revusiran (familial amyloidotic cardiomyopathy – phase III). The successful development and commercialization of these candidates are crucial for the company."
http://finance.yahoo.com/news/alnylam-reports-publication-data-hemophilia-204508874.html
"Alnylam currently has no approved product in its portfolio. Although the company has a number of pipeline candidates, most of the candidates are in early or mid stages of development. The company has only a couple of late-stage candidates in its pipeline – patisiran (TTR-mediated amyloidosis in familial amyloidotic polyneuropathy patients – phase III) and revusiran (familial amyloidotic cardiomyopathy – phase III). The successful development and commercialization of these candidates are crucial for the company."
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
